Although very rare, it is very important to remember that there is a risk of sympathetic ophthalmia in severe eye injuries, though prophylaxis by removing the eye remains controversial
📌 3 Key Takeaways
🎯
Objective & Hypothesis:An 18-year-old male with an open globe injury, eyelid lacerations, and orbital wall fractures related to severe blunt trauma was referred to the clinic for primary evisceration and eyelid repair.
📊
Key Findings & Data:A month later, the patient accepted the removal of the eye due to progressive phthisis bulbi and underwent evisceration 5 weeks after the injury.
💡
Conclusion & Impact:Although very rare, it is very important to remember that there is a risk of sympathetic ophthalmia in severe eye injuries, though prophylaxis by removing the eye remains controversial
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
An 18-year-old male with an open globe injury, eyelid lacerations, and orbital wall fractures related to severe blunt trauma was referred to the clinic for primary evisceration and eyelid repair. As the patient refused the removal of the eye, the globe, eyelids, and canaliculi were sutured primarily. A month later, the patient accepted the removal of the eye due to progressive phthisis bulbi and underwent evisceration 5 weeks after the injury. He was followed up for 2 years after the second surgery and had an acceptable cosmetic result without any complication. Although very rare, it is very important to remember that there is a risk of sympathetic ophthalmia in severe eye injuries, though prophylaxis by removing the eye remains controversial
🔖
Cite This Article
ÖZTÜRKER, C., KAYNAK, P., KARABULUT, G. Ö., FAZIL, K., YILDIRIM, Y., OCAK, O. B. (2018). Management of Open Globe Injuries and Concern About Sympathetic Ophthalmia: A Case Report. BEYOGLU EYE JOURNAL, Cilt: 3 - Sayı: 1, 38–42. https://ajindex.com/articles/146237
Allen JC. Sympathetic ophthalmia, a disappearing disease. JAMA 1969;209:1090
Liddy L, Stuart J. Sympathetic ophthalmia in Canada. Can J Ophthalmol 1972;7:157–9
Kraus-Mackiw E, Müller-Ruchholtz W. Sympathetic eye diseases: diagnosis and therapy. Klin Monbl Augenheilkd 1980;176:131–9
Tseng VL, Matoso A, Hofmann RJ. Sympathetic ophthalmia following enucleation. Graefes Arch Clin Exp Ophthalmol 2013;251:393–4
Green WR, Maumenee AE, Sanders TE, Smith ME. Sympathetic uveitis following evisceration. Trans Am Acad Ophthalmol Otolaryngol 1972;76:625–44
Griepentrog GJ, Lucarelli MJ, Albert DM, Nork TM. Sympathetic ophthalmia following evisceration: a rare case. Ophthal Plast Reconstr Surg 2005;21:316–8
Kilmartin DJ, Forrester JV, Dick AD. Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis. Ocul Immunol Inflamm 1998;6:101–9
Levine MR, Pou CR, Lash RH. The 1998 Wendell Hughes Lecture. Evisceration: is sympathetic ophthalmia a concern in the new millennium? Ophthal Plast Reconstr Surg 1999;15:4–8
Savar A, Andreoli MT, Kloek CE, Andreoli CM. Enucleation for open globe injury. Am J Ophthalmol 2009;147:595–600.e1
Timothy NH, Freilich DE, Linberg JV. Evisceration versus enucleation from the ocularist's perspective. Ophthal Plast Reconstr Surg 2003;19:417–20
Bilyk JR. Enucleation, evisceration, and sympathetic ophthalmia. Curr Opin Ophthalmol 2000;11:372–86
Bellan L. Sympathetic ophthalmia: a case report and review of the need for prophylacticenucleation. Can J Ophthalmol 1999;34:95–8
Galor A, Davis JL, Flynn HW Jr, Feuer WJ, Dubovy SR, Setlur V, et al. Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol 2009;148:704–10.e2.